Fact Check
Verifiable facts from the talks, checked item by item online; fact-checked on August 12, 2026.
| Talk | Claim | Verdict | Finding | Source |
|---|---|---|---|---|
| Opening | Lin Ching-Yi is the Deputy Minister of the Ministry of Health and Welfare | Confirmed | Confirmed; she has held the post since May 2024. | mohw.gov.tw |
| Opening | Wu Mai-Szu is the President of Taipei Medical University | Confirmed | Confirmed; he took office in 2023 and specializes in nephrology. | history.tmu.edu.tw |
| Opening | Shih Chun-Ming is the Superintendent of TMU Hospital | Confirmed | Confirmed; he became the 14th superintendent in March 2023. | businesstoday.com.tw |
| Opening | Lin Chien-Huang is the Chairman of the TMU Board | Partly correct | Conflicting evidence: onsite slides and the emcee referred to him as Chairman, but the TMU history website lists Chen Jui-Chieh as Chairman since 2022, with Lin Chien-Huang listed only as a board member (he was previously President from 2017-2023). This may reflect an outdated webpage or an on-site title error; flagged as unresolved. | history.tmu.edu.tw |
| Opening | The 'Health Coin' program launches in 2026 | Confirmed | Confirmed. It's the MOHW's health-incentive points program (earning points for vaccines, checkups, and screenings). Originally planned for April 2026, it has been delayed several times; as of this fact-check it's slated for September-October 2026. | businessweekly.com.tw |
| Opening | A dedicated law now governs the National Health Insurance database (following Constitutional Court Judgment No. 13 of 2022) | Confirmed | Confirmed. The National Health Insurance Data Management Act passed its third reading in December 2025, establishing an opt-out right and fines of up to NT$10 million for illegal use. | mohw.gov.tw |
| Opening | TMU Hospital celebrates its 50th anniversary in 2026 | Confirmed | Confirmed; the hospital was founded on August 6, 1976. | udn.com |
| Sheu | Sheu Huey-Herng is a Distinguished Investigator and Deputy Director-General of the National Health Research Institutes | Confirmed | Confirmed, effective since January 16, 2023. His English name is Wayne Huey-Herng Sheu; he previously served as Superintendent of Taichung Veterans General Hospital. | enews.nhri.edu.tw |
| Sheu | The '888 Plan' targets 80% enrolled in care networks, 80% receiving lifestyle counseling, and 80% reaching control goals | Partly correct | Partly correct. The three 80% figures are accurate, but the official target year is 2030. The '2028 Target' shown on the slide is actually an interim KPI from the Healthy Taiwan Promotion Committee, a different tier of goal. | mohw.gov.tw |
| Sheu | Among Taiwan's top ten causes of death, hypertension/hyperglycemia/hyperlipidemia-related chronic diseases cause about 62,000 deaths a year (30%) | Confirmed | Confirmed. In 2024, the five hypertension/hyperglycemia/hyperlipidemia-related causes of death totaled 61,009 deaths, or 30.3%, matching the claim. | dep.mohw.gov.tw |
| Sheu | Cancer caused 53,126 deaths (26%) | Partly correct | Partly correct. That figure is from 2023 (25.8%); the latest 2024 data shows 54,032 deaths (26.8%). | commonhealth.com.tw |
| Sheu | Taiwan entered a super-aged society in 2025 | Confirmed | Confirmed. By the end of 2025, residents aged 65 and over made up 20.06% of the population (4.673 million people). | cna.com.tw |
| Sheu | Tsai MK et al., PLoS Medicine 2025 (the cardiovascular-kidney-metabolic cohort study) | Confirmed | Confirmed. All figures match: 515,602 participants, 71.5% CKM prevalence, an average 2.5-year interval between the two health checks, and 18.3% showing progression. DOI 10.1371/journal.pmed.1004629. | journals.plos.org |
| Sheu | TPMI phase two targets 500,000 participants | Unverified | Unverified. No public source confirms a '500,000-person phase two.' TPMI phase one closed enrollment in December 2022 with about 570,000 participants, and in December 2025 two Nature papers were published using data from 560,000 of them. The speaker's on-site claim of aiming for a phase two that re-enrolls 300,000 plus recruits 200,000 new participants has no public documentation yet. | cna.com.tw |
| Sheu | NBCT, the national biobank integration platform, was established in 2019 | Confirmed | Confirmed. Founded in October 2019, it now integrates 33 biobanks with over 836,000 participants. (The slide's figures of 939,000 registered records and 563,000 unique patients use a different counting method.) | nbct.nhri.org.tw |
| Sheu | The three 2025 papers cited on the slide (two in Nature, one in Nature Communications) | Confirmed | Confirmed. These are the TPMI cohort papers published in 2025, covering cohort construction, a polygenic risk score for the Han Chinese population, and pharmacogenomics. | sinica.edu.tw |
| Shyr | Yu Shyr is Professor and Chair of the Department of Biostatistics at Vanderbilt University Medical Center | Confirmed | Confirmed; she also holds the Harold L. Moses Chair in Cancer Research. | biostatistics.vmcweb.org |
| Shyr | The PILOT trial (Semler MW et al., NEJM 2022;387:1759-69) | Confirmed | Confirmed. A pragmatic cluster-randomized, cluster-crossover trial comparing SpO2 targets of 90%, 94%, and 98% (ranges 88-92 / 92-96 / 96-100); the main finding was no significant difference in ventilator-free days across the three groups. | nejm.org |
| Shyr | A JAMA paper (March 19, 2024) used machine learning to analyze personalized oxygen targets | Confirmed | Confirmed. First author Kevin G. Buell, JAMA 2024;331(14):1195-1204. The ML model analyzed PILOT trial data and validated externally on ICU-ROX; personalized targets may reduce mortality. | pubmed.ncbi.nlm.nih.gov |
| Shyr | Ford & Norrie, 'Pragmatic Trials' (NEJM 2016;375:454-463) | Confirmed | Confirmed; part of the 'Changing Face of Clinical Trials' series. | nejm.org |
| Shyr | The Qini statistic | Confirmed | Confirmed. A performance metric for uplift modeling (a generalization of the Gini coefficient to incremental-effect settings), used to measure how well a model ranks people by who benefits most; common in marketing and precision medicine. | metricgate.com |
| Shyr | The cfDNA/Harmony prenatal screening study | Confirmed | Confirmed, most likely referring to the NEXT study (Norton ME et al., NEJM 2015;372:1589-97): among 18,955 pregnant women, the Harmony test detected 100% of Trisomy 21 cases versus 78.9% for conventional screening. | nejm.org |
| Mairal | Stanford Biodesign: 60+ companies, 22 million patients, 25 years | Partly correct | Partly correct. The official website (as of August 2026) lists 58 companies, 22 million+ patients, and 25 years since 2001; the patient count and years match, but the talk rounded the company count up slightly. | med.stanford.edu |
| Mairal | US healthcare spending is 'nearly 40% of GDP' (as stated in the talk) | Contradicted | Contradicted. This appears to be a clear slip of the tongue: CMS data puts 2024 US healthcare spending at 18.0% of GDP (5.3 trillion dollars). | cms.gov |
| Mairal | Anurag Mairal is the founding chair of the APAC Biodesign Alliance | Confirmed | Confirmed. The alliance was renamed from BME-IDEA APAC, with Mairal serving as Founding Chair. | eppicglobal.org |
| Mairal | Mairal's title, as stated on the slide | Confirmed | Confirmed; matches his official Stanford profile. | profiles.stanford.edu |
| Mairal | Asia-Pacific accounts for 60% of world population, 30% of nominal GDP, and 50% of GDP at PPP | Partly correct | Roughly correct. The 60% population share checks out; nominal GDP share is closer to 36-37% and PPP share is about 46%. A more precise phrasing would be about 60% of population, over a third of nominal GDP, and nearly half of PPP-adjusted GDP. | imf.org |
| Mairal | Taiwan startup example 1: Jungu's Stacable (orthopedics) | Partly correct | Partly correct. The company exists (a Taiwanese spinal device maker) with a tethering product called Stacable; its official tagline is Minimum Trauma, Maximum Stability (worded slightly differently on the slide). The IMPLANET JAZZ PF shown on the same slide is a separate product from the French company Implanet, and should be read as a side-by-side reference, not the same company. | jungu.com.tw |
| Mairal | Taiwan startup example 2: OmniSurgica's Omni-SureEye Recorder | Partly correct | Partly correct. The company exists (a Taipei startup building AI-powered endoscopic surgery imaging), but its current official product name is TranScope; no official source confirms the name Omni-SureEye Recorder, which may be an unreleased product or an older name used on the slide. | omnisurgica.com |
| Mairal | Taiwan startup example 3: a wearable device for peripheral neuropathy | Unverified | Unverified. The slide didn't name a company, and no matching company could be found. | — |
| Bartlett | Title: Associate Director, Corporate Innovation & Education | Confirmed | Confirmed; he still held this title as of the 2026 verification. | biodesign.stanford.edu |